R3T
40 mg / 3 mLAn investigational triple-receptor agonist for metabolic research.
AERVYN COLLECTION · UAE
5 presentationsMetabolic & weight
Investigational compounds associated with appetite and metabolic signalling.
20 mg / 3 mLCagriSemaCagrilintide + semaglutide 20 mg
CagriSema
20 mg / 3 mLAmylin and GLP-1 signalling in metabolic research.
18 mg / 3 mLLiraglutideLiraglutide 18 mg
Liraglutide
18 mg / 3 mLGLP-1 signalling, glucose control and weight research.
10 mg / 3 mLSemaglutideSemaglutide 10 mg
Semaglutide
10 mg / 3 mLGLP-1 signalling, appetite and metabolic outcomes.
30 mg / 3 mLTirzepatideTirzepatide 30 mg
Tirzepatide
30 mg / 3 mLGIP and GLP-1 signalling, appetite and metabolic outcomes.